Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2, replacing v3.0.1. The Back to Top link was removed, with no other substantive changes observed.
    Difference
    0.1%
    Check dated 2025-09-14T21:44:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Lung cancer under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T18:10:20.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while also removing several location-related entries and specific medical information.
    Difference
    2%
    Check dated 2025-08-31T12:24:56.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:48:16.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:41:09.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-01T19:00:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.